<--- Back to Details
First PageDocument Content
Biology / Antibody-drug conjugate / Milatuzumab / Targeted therapy / Brentuximab vedotin / Yttrium (90Y) clivatuzumab tetraxetan / Hydrazone / Gemtuzumab ozogamicin / Monomethyl auristatin E / Monoclonal antibodies / Medicine / Pharmacology
Date: 2013-10-18 09:49:14
Biology
Antibody-drug conjugate
Milatuzumab
Targeted therapy
Brentuximab vedotin
Yttrium (90Y) clivatuzumab tetraxetan
Hydrazone
Gemtuzumab ozogamicin
Monomethyl auristatin E
Monoclonal antibodies
Medicine
Pharmacology

Microsoft PowerPoint - World ADC San Francisco[removed]CLS

Add to Reading List

Source URL: www.immunomedics.com

Download Document from Source Website

File Size: 1,27 MB

Share Document on Facebook

Similar Documents

Microsoft Word - IMMUNOMEDICS AWARDED DOD GRANT FOR MILATUZUMAB IN LUPUS.doc

Microsoft Word - IMMUNOMEDICS AWARDED DOD GRANT FOR MILATUZUMAB IN LUPUS.doc

DocID: oXlx - View Document

Microsoft PowerPoint - World ADC San Francisco[removed]CLS

Microsoft PowerPoint - World ADC San Francisco[removed]CLS

DocID: etxf - View Document

Microsoft PowerPoint - Corporate Presentation June 2014

Microsoft PowerPoint - Corporate Presentation June 2014

DocID: enxW - View Document